Tag: CLVS

  • Mid Cap Most Volatile: Valhi (NYSE:VHI), Synageva BioPharma (NASDAQ:GEVA), Clovis Oncology (NASDAQ:CLVS), Nimble Storage (NYSE:NMBL)

    Valhi, Inc. (NYSE:VHI) begin trading ex-dividend on March 06, 2014. A cash dividend payment of $0.05 per share is scheduled to be paid on March 27, 2014. Valhi, Inc. (NYSE:VHI) shares after opening at $11.00 moved to $11.06 on last trade day and at the end of the day closed at $10.05. Company price to sales ratio in past twelve months was calculated as 1.77 and price to cash ratio as 29.71. Valhi, Inc. (NYSE:VHI) showed a negative weekly performance of -5.72%.

    Shares of Synageva BioPharma Corp (NASDAQ:GEVA) have received an average rating of “Hold” from the nine brokerages that are covering the stock, Analyst Ratings.Net reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating on the company. Synageva BioPharma Corp (NASDAQ:GEVA) shares fell -9.48% in last trading session and ended the day on $90.67. GEVA return on equity ratio is recorded as -25.00% and its return on assets is -24.10%. Synageva BioPharma Corp (NASDAQ:GEVA) yearly performance is 70.82%.

    In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Clovis Oncology Inc. (NASDAQ:CLVS) was identified as having a larger market cap than the smaller end of the S&P 500. Clovis Oncology Inc. (NASDAQ:CLVS) shares moved down -6.86% in last trading session and was closed at $79.91, while trading in range of $78.58 – $86.74. Clovis Oncology Inc. (NASDAQ:CLVS) year to date (YTD) performance is 32.59%.

    Equities research analysts at Longbow Research started coverage on shares of Nimble Storage (NASDAQ:NMBL) in a research note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating on the stock. Nimble Storage Inc. (NYSE:NMBL) weekly performance is -13.25%. On last trading day company shares ended up $37.98. Nimble Storage Inc. (NYSE:NMBL) distance from 50-day simple moving average (SMA50) is -17.62%. Analysts mean target price for the company is $56.67.